Relationship Between Cognitive Ability and Phase Angle in Older Adults with Cardiovascular Disease: A Cross-Sectional Study

认知能力与老年心血管疾病患者相位角的关系:一项横断面研究

阅读:1

Abstract

BACKGROUND: Cognitive decline in older adults with Cardiovascular Disease (CVD) is frequently mediated by chronic inflammation, oxidative stress, and cellular dysfunction. However, reliable biomarkers for early detection are still lacking. Phase angle (PhA), a sensitive bioelectrical impedance analysis (BIA) parameter reflecting cellular health and nutritional status, may serve as a novel tool for detecting cognitive impairment in this population. METHODS: In this cross-sectional study, 340 CVD patients (mean age: 80.8 ± 8.0 years; 36.5% male) were recruited from the Zhejiang Elderly Health Monitoring Cohort. PhA was measured using the InBody S10. Participants were stratified into cognitive impairment (n = 138) and cognitively normal (n = 202) groups based on Mini-Mental State Examination (MMSE) scores adjusted for education level. Group differences were analyzed via independent t-tests, Mann-Whitney U-tests, and chi-square tests. Binary logistic regression evaluated the association between PhA and cognitive ability. RESULTS: The cognitive impairment group exhibited significantly lower PhA (P < 0.001), older age, reduced grip strength, smaller calf circumference, slower gait speed (all P < 0.001), along with lower education levels and poorer physical activity intensity (both P<0.01). Additionally, they demonstrated worse performance in activities of daily living, nutritional status, balance, and swallowing function, along with greater frailty severity (all P < 0.001). Multivariate analysis confirmed PhA as an independent predictor of cognitive ability after adjusting for age, education, physical activity, grip strength, gait speed, and calf circumference (β = -0.474, OR = 0.62, 95% CI: 0.43-0.89, P = 0.01). ROC curve analysis revealed an optimal PhA threshold of 4.75° for cognitive impairment detection (specificity: 70.3%). CONCLUSION: Reduced PhA is independently associated with cognitive impairment risk in older CVD patients. Its noninvasive, cost-effective measurement supports its potential as a community screening tool and may provide a critical target for early intervention.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。